- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06474949
Local Anesthetic for Plateau Fractures
June 19, 2024 updated by: Jonah Hebert-Davies, University of Washington
Subjects may receive an injection at the end of the surgery to fix their broken leg that may reduce their pain and hospital stay
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
Subjects will be randomized to bupivicaine or saline injection in the joint at the end of Open Reduction Internal Fixation of the tibial plateau fracture
Study Type
Interventional
Enrollment (Estimated)
100
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Julie Agel
- Phone Number: 206.744.4113
- Email: bagel@uw.edu
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age >=18 year ,
- tibial plateau fracture undergoing Open Reduction and fixation"
Exclusion:
- allergy to bupivacaine
- Prolonged external fixator use
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Saline
|
Injection at end of Open Reduction Internal Fixation
Other Names:
|
|
Active Comparator: Bupivacaine
|
Injection at end of Open Reduction Internal Fixation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain in the knee visual analogue scale 11 point scale 0(no pain) -10 (worst pain)
Time Frame: From date of hospitalization to end of follow-up at 6 months
|
Pain at time of visit
|
From date of hospitalization to end of follow-up at 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Length of stay for hospitalization
Time Frame: From date of hospitalization up to one month post surgery
|
Length of stay for hospitalization
|
From date of hospitalization up to one month post surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jonah Hebert-Davies, University of Washington
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
August 1, 2024
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
August 1, 2027
Study Registration Dates
First Submitted
March 29, 2024
First Submitted That Met QC Criteria
June 19, 2024
First Posted (Actual)
June 26, 2024
Study Record Updates
Last Update Posted (Actual)
June 26, 2024
Last Update Submitted That Met QC Criteria
June 19, 2024
Last Verified
June 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00017105
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tibial Plateau Fractures
-
Second Affiliated Hospital of Soochow UniversityCompleted
-
Universitaire Ziekenhuizen KU LeuvenTerminated
-
Pedro-José Torrijos-GarridoRecruitingTibial Plateau FractureSpain
-
Sohag Universitysohag university hospitalRecruitingTibial Plateau Fractures Schatzker Type IIEgypt
-
National Trauma CenterCompletedTibial Plateau Fracture | Tibial Plateau Fractures
-
Second Affiliated Hospital of Soochow UniversityCompletedTibial Plateau FractureChina
-
Poitiers University HospitalCompletedSchatzker Type 2 or 3 Tibial Plateau FractureFrance, Martinique
-
Cairo UniversityEnrolling by invitationTibial Plateau FracturesEgypt
-
Medical College of WisconsinWithdrawnTibial Plateau FracturesUnited States
-
University of UtahEnrolling by invitationTibial Shaft Fracture | Tibial Plateau FractureUnited States
Clinical Trials on Bupivacaine injection
-
Jiangsu HengRui Medicine Co., Ltd.CompletedPostoperative Local AnalgesiaChina
-
Second Affiliated Hospital of Nanchang UniversityRecruiting
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingLocal Analgesia Via Nerve BlockChina
-
Ataturk UniversityEnrolling by invitationHip Osteoarthritis | Osteonecrosis of the Femoral Head | Avascular Necrosis of Femur Head | Dysplasia of Hip Joint | Hip SurgeriesTurkey (Türkiye)
-
The University of Texas Health Science Center at...Completed
-
University of South FloridaCompletedPain, Postoperative | Carpal Tunnel SyndromeUnited States
-
Broward HealthCompleted
-
University of Texas Southwestern Medical CenterCompleted
-
Centre intégré universitaire de santé et de services...Recruiting
-
Antalya Training and Research HospitalNot yet recruitingStellate Ganglion BlockTurkey (Türkiye)